covid antibody drug 11-10-20 ap.jpeg
This photo provided by Eli Lilly shows the drug Bamlanivimab. On Monday, Nov. 9, 2020, the Food and Drug Administration cleared emergency use of Bamlanivimab, the first antibody drug to help the immune system fight COVID-19. The drug is for people 12 and older with mild or moderate COVID-19 not requiring hospitalization. (Courtesy of Eli Lilly via AP)
As featured on
Some COVID-19 patients will be able to receive an antibody infusion treatment from U of L Health that is designed to help the body fight off the virus.
As of last month, the U.S. only used 20% of the company's antibody treatment supply partially because how difficult the treatment is to administer.
The recent findings were serious enough to change emergency use authorization for the products according to the FDA.
